1. Home
  2. DECK vs RDY Comparison

DECK vs RDY Comparison

Compare DECK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deckers Outdoor Corporation

DECK

Deckers Outdoor Corporation

HOLD

Current Price

$96.88

Market Cap

14.2B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$11.85

Market Cap

11.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DECK
RDY
Founded
1973
1984
Country
United States
India
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
11.8B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
DECK
RDY
Price
$96.88
$11.85
Analyst Decision
Buy
Strong Buy
Analyst Count
23
1
Target Price
$122.45
$16.90
AVG Volume (30 Days)
2.2M
2.9M
Earning Date
05-21-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
10.90
N/A
EPS
0.94
N/A
Revenue
$5,472,296,000.00
N/A
Revenue This Year
$11.16
$7.72
Revenue Next Year
$6.96
$3.50
P/E Ratio
$14.19
$18.67
Revenue Growth
9.76
N/A
52 Week Low
$78.91
$11.36
52 Week High
$125.45
$15.67

Technical Indicators

Market Signals
Indicator
DECK
RDY
Relative Strength Index (RSI) 42.05 32.69
Support Level $97.84 $11.36
Resistance Level $106.11 $14.08
Average True Range (ATR) 3.68 0.27
MACD -0.36 -0.07
Stochastic Oscillator 35.81 28.93

Price Performance

Historical Comparison
DECK
RDY

About DECK Deckers Outdoor Corporation

Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: